Ottawa biotech startup gets US$1M boost in quest to find treatment for muscle-wasting disease
Scientists at Satellos Bioscience are working on a drug that will help regenerate muscle tissue in patients who suffer from Duchenne muscular dystrophy.
Skip to content
Michael Rudnicki
Get our email newsletters
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
By signing up you agree to our Terms of Use and Privacy Policy. You may unsubscribe at any time.
The Latest
Video
OBJ360
Sponsored
Sponsored
The Ottawa Hospital Foundation’s Campaign to Create Tomorrow
The $500-million fundraising campaign is the largest in our city’s history. It will reshape the future of healthcare in Ottawa and beyond.
EXPERT BLOGS
What about the First Home Savings Account?
Joelle Hall
10 essential considerations when selling your business
Gobel, Sampson & Associates Private Wealth Management
